• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply
Sort by Relevance
CSV RIS
Search Results [15895 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2018 Belgian Health Care Knowledge Centre (KCE) Responsible use of high-risk medical devices: the example of 3D printed medical devices
2018 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Echocardiography: Guideline recommendations and options to identify inappropriate use as well as usage rate in Austria
2018 Belgian Health Care Knowledge Centre (KCE) MammaPrint® test for personalised management of adjuvant chemotherapy decisions in early breast cancer
2018 NIHR Health Services and Delivery Research programme Understanding new models of integrated care in developed countries: a systematic review
2018 NIHR Health Services and Delivery Research programme A staff training intervention to improve communication between people living with dementia and health-care professionals in hospital: the VOICE mixed-methods development and evaluation study
2018 NIHR Health Technology Assessment programme Treatments for dry age-related macular degeneration and Stargardt disease: a systematic review
2018 NIHR Health Technology Assessment programme What works to increase attendance for diabetic retinopathy screening? An evidence synthesis and economic analysis
2018 NIHR Health Technology Assessment programme Screening women aged 65 years or over for abdominal aortic aneurysm: a modelling study and health economic evaluation
2018 NIHR Health Technology Assessment programme Risk scores to guide referral decisions for people with suspected ovarian cancer in secondary care: a systematic review and cost-effectiveness analysis
2018 NIHR Health Technology Assessment programme Therapeutic hypothermia to reduce intracranial pressure after traumatic brain injury: the Eurotherm3235 RCT
2018 NIHR Health Technology Assessment programme Everolimus, lutetium-177 DOTATATE and sunitinib for advanced, unresectable or metastatic neuroendocrine tumours with disease progression: a systematic review and cost-effectiveness analysis
2018 NIHR Health Technology Assessment programme Behavioural activation versus guided self-help for depression in adults with learning disabilities: the BeatIt RCT
2018 NIHR Health Technology Assessment programme Adjunctive colposcopy technologies for assessing suspected cervical abnormalities: systematic reviews and economic evaluation
2018 NIHR Health Technology Assessment programme Pharmacological and non-pharmacological interventions for non-respiratory sleep disturbance in children with neurodisabilities: a systematic review
2018 NIHR Health Technology Assessment programme Brain and spinal stimulation therapies for phantom limb pain: a systematic review
2018 NIHR Health Technology Assessment programme Assessing prognosis and prediction of treatment response in early rheumatoid arthritis: systematic reviews
2018 NIHR Health Technology Assessment programme Bariatric surgery, lifestyle interventions and orlistat for severe obesity: the REBALANCE mixed-methods systematic review and economic evaluation
2018 NIHR Health Technology Assessment programme Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation
2018 NIHR Health Technology Assessment programme Contrast-enhanced ultrasound and/or colour duplex ultrasound for surveillance after endovascular abdominal aortic aneurysm repair: a systematic review and economic evaluation
2018 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Dropouts in Psychotherapy. Part I: Predictors, theories and models to explain and recommend courses of action to avoid discontinuation of therapy. Part II: "Overview of Reviews" on dropouts in psychotherapy
2018 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Options to identify inappropriate use of MRI, Part 3
2018 NIHR Public Health Research (PHR) programme Child food insecurity in the UK: a rapid review
2018 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Osimertinib (Tagrisso®) for the initial treatment of EGFR-mutated advanced non–small-cell lung cancer (NSCLC)
2018 Swiss Federal Office of Public Health (FOPH) Knee arthroscopy for the treatment of degenerative changes
2018 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Daratumumab (Darzalex®) in combination with bortezomib, melphalan and prednisone for untreated myeloma
2018 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Re-orientation of the Austrian parent-child preventive care programme. Part XI: Further development of the mother-child-pass: Screening recommendations of the expert working group for pregnancy, puerperium and early childhood (0-6 years)
2018 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Stereotactic radiotherapy, proton therapy and irreversible electroporation for the treatment of localised prostate cancer
2018 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Endobronchial valve implantation for emphysema. Update 2018
2018 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) High-intensity focused ultrasound for the treatment of prostate cancer. 1st Update 2018
2018 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) (Percutaneous) left atrial appendage closure for the prevention of thromboembolic events in patients with atrial fibrillation. 3rd Update 2018
2018 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Subcutaneous implantable cardioverter defibrillator (ICD)
2018 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Lymphovenous anastomoses in patients with primary and secondary lymphoedema
2018 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Allogeneic mesenchymal stem cells for Crohn’s disease-associated complex perianal fistulas
2018 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Meniscal allograft transplantation for post-meniscectomy syndrome
2018 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Baroreceptor activation therapy for treatment-resistant hypertension
2018 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Carbon ion beam radiotherapy (CIRT) for cancer treatment: a systematic review of effectiveness and safety for 12 oncologic indications
2018 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Nivolumab (Opdivo®) in combination with ipilimumab (Yervoy®) for the first-line treatment of patients with advanced RCC
2018 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Pembrolizumab (Keytruda®) in combination with chemotherapy for the treatment of metastatic non-small-cell lung cancer (NSCLC)
2018 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) External stimulation of the trigeminal nerve for the prevention and acute treatment of episodic and chronic migraine
2018 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) PET/PET-CT Evidence for need based planning in Germany and Austria
2018 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Supporting children who have parents with mental disorders in Tyrol: A mapping of existing Tyrolean support and societal structures
2018 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Prevalence of mental disorders and uptake of mental health services in Tyrol: An analysis of epidemiological literature and administrative data from the Tyrolean health insurance
2018 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Inhalation sedation with laughing gas (N2O) in dentistry – organisational and professional aspects and a systematic review of efficacy and safety
2018 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Drug reimbursement in the inpatient sector in Austria: Approaches for a transparent and evidence-based process, taking into account international experience
2018 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Enzalutamide (Xtandi®) in patients with nonmetastatic, castration-resistant prostate cancer (CRPC)
2018 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Ibrutinib (Imbruvica®) in combination with rituximab for the treatment of Waldenström’s macroglobulinaemia
2018 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Wearable cardioverter-defibrillator (WCD) therapy in primary and secondary prevention of sudden cardiac arrest in patients at risk. Update 2018
2018 Andalusian Health Technology Assessment Area (AETSA) Electrical stimulation of peripheral nerves for treating chronic refractory pain
2018 Andalusian Health Technology Assessment Area (AETSA) [Digital tomosynthesis in breast cancer: meta-analysis]
2018 Andalusian Health Technology Assessment Area (AETSA) Bibliographic review on the diagnosis, treatment and follow-up of Kawasaki disease
2018 Andalusian Health Technology Assessment Area (AETSA) 18F-FDG PET in early diagnosis of degenerative diseases of the central nervous system
2018 Andalusian Health Technology Assessment Area (AETSA) Prognostic genomic tests in early breast cancer: up-date of evidence.
2018 Andalusian Health Technology Assessment Area (AETSA) Alectinib as monotherapy for the first-line treatment of adult patients with ALK positive advanced non-small cell lung cancer. EUnetHTA adopted HTA report
2018 Andalusian Health Technology Assessment Area (AETSA) Midostaurin with standard chemotherapy in FLT3-positive acute myeloid leukaemia. EUnetHTA adopted HTA report.
2018 Andalusian Health Technology Assessment Area (AETSA) Quality criteria and good practices in organizations dedicated to the Health Technologies Assessment
2018 Andalusian Health Technology Assessment Area (AETSA) Regorafenib indicated as monotherapy for the treatment of adult patients with hepatocellular carcinoma who have been previously treated with sorafenib. EUnetHTA adopted HTA report.
2018 National Authority for Assessment and Accreditation in Healthcare (INEAS) Le trastuzumab dans le traitement du cancer du sein HER2 positif au stade précoce et localement avancé 
2018 Health Quality Ontario (HQO) Electronic Monitoring Systems to Assess Urinary Incontinence: A Health Technology Assessment
2018 Basque Office for Health Technology Assessment (OSTEBA) [HIFU —High intensity focused ultrasound— in essential tremor]
2018 Basque Office for Health Technology Assessment (OSTEBA) [Evaluation of the scientific evidence on nipple-areola complex micropigmentation, requirements for its proper implementation and costs]
2018 Basque Office for Health Technology Assessment (OSTEBA) [Immunological faecal occult blood test for patients with symptoms compatible with colorectal cancer: recommendation of Clinical Practice Guides and use in the National Health System]
2018 Basque Office for Health Technology Assessment (OSTEBA) [Radiofrequency tonsil reduction]
2018 Basque Office for Health Technology Assessment (OSTEBA) [Effectiveness and safety of bone suppression technology for the detection of lung cancer and indications for its use]
2018 Basque Office for Health Technology Assessment (OSTEBA) [Strategies for promoting and strengthening evidence-based nursing in the Basque Country]
2018 Basque Office for Health Technology Assessment (OSTEBA) [Checklist for ethical and legal domains analysis]
2018 Adelaide Health Technology Assessment (AHTA) Extended half-life clotting factor concentrates for the treatment of haemophilia A and B
2018 Adelaide Health Technology Assessment (AHTA) Heritable mutations which increase risk in colorectal and endometrial cancer
2018 Adelaide Health Technology Assessment (AHTA) Anti-Mullerian Hormone (AMH) testing for female patients who will or have received gonadotoxic treatment
2018 Health Quality Ontario (HQO) Bilateral Cochlear Implantation: A Health Technology Assessment
2018 Adelaide Health Technology Assessment (AHTA) Pharmaceutical Benefits Scheme post-market review of Pulmonary Arterial Hypertension medicines
2018 Adelaide Health Technology Assessment (AHTA) Processing and cryopreservation of ovarian tissue prior to or after gonadotoxic treatment to preserve fertility in females for the future
2018 Adelaide Health Technology Assessment (AHTA) Systematic literature review on the association between alcohol consumption and mental health disorders. Evidence Evaluation Report
2018 Health Technology Wales (HTW) Sacral nerve stimulation to treat faecal incontinence that cannot be controlled with conservative management
2018 Penn Medicine Center for Evidence-based Practice (CEP) Acid Suppression Therapy for Oncology Patients
2018 Health Technology Wales (HTW) Faecal immunochemical test-based prediction tools for the assessment of people presenting to primary care with symptomatic bowel disease
2018 Health Quality Ontario (HQO) Internet-Delivered Cognitive Behavioural Therapy for Major Depression and Anxiety Disorders: A Health Technology Assessment
2018 Health Quality Ontario (HQO) Remote Monitoring of Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy and Permanent Pacemakers: A Health Technology Assessment
2018 Health Quality Ontario (HQO) Magnetic Resonance-Guided Focused Ultrasound Neurosurgery for Essential Tremor: A Health Technology Assessment
2018 Health Quality Ontario (HQO) Structured Education and Neuromuscular Exercise Program for Hip and/or Knee Osteoarthritis: A Health Technology Assessment
2018 Adelaide Health Technology Assessment (AHTA) Systematic literature review on the association between alcohol consumption and mental health disorders. Technical Report
2018 Penn Medicine Center for Evidence-based Practice (CEP) Update: Best practices for central venous catheter removal
2018 Penn Medicine Center for Evidence-based Practice (CEP) Point-of Care Ultrasound for Acute Respiratory Distress
2018 Penn Medicine Center for Evidence-based Practice (CEP) Monitoring of Anticoagulation in Patients on Extracorporeal Membrane Oxygenation
2018 Penn Medicine Center for Evidence-based Practice (CEP) Transjugular Intrahepatic Portosystemic Shunts for Patients with Acute Variceal Bleeding
2018 Penn Medicine Center for Evidence-based Practice (CEP) Update: Anticoagulation Management in Paracentesis and Thoracentesis
2018 Penn Medicine Center for Evidence-based Practice (CEP) Home Administration of Intravenous Immunoglobulin
2018 Penn Medicine Center for Evidence-based Practice (CEP) Using Patient Generated Health Data in an Electronic Health Record
2018 Penn Medicine Center for Evidence-based Practice (CEP) Management of Post-Biopsy Renal Bleeding
2018 Penn Medicine Center for Evidence-based Practice (CEP) Location of Implanted Ports for Chemotherapy
2018 Penn Medicine Center for Evidence-based Practice (CEP) Best Practices for Treating Acute/Severe Hyperkalemia in the Hospital Setting
2018 Penn Medicine Center for Evidence-based Practice (CEP) Guidelines for Electrocardiography on Arrival to the Emergency Department
2018 Penn Medicine Center for Evidence-based Practice (CEP) Guidelines for Management of Acute Hydronephrosis
2018 Norwegian Institute of Public Health (NIPH) Therapist-supported internet therapy for mental disorders – a health technology assessment
2018 Norwegian Institute of Public Health (NIPH) EXOGEN™ in the treatment of non-union fractures. A single technology assessment
2018 Norwegian Institute of Public Health (NIPH) Effectiveness and safety of nitrous oxide as sedation regimen in children – an HTA
2018 Norwegian Institute of Public Health (NIPH) Autologous hematopoietic stem cell transplantation (AHSCT) for Diffuse Systemic Sclerosis. Health Technology Assessment
2018 Norwegian Institute of Public Health (NIPH) The MicraTM Transcatheter Pacing System, a leadless pacemaker, in patients indicated for single-chamber ventricular pacemaker implantation: A single technology assessment
2018 Norwegian Institute of Public Health (NIPH) 177Lutetium-based peptide receptor radionuclide therapy for treating neuroendocrine tumours: a health technology assessment
2018 Norwegian Institute of Public Health (NIPH) Diagnostic accuracy, clinical effectiveness and budget impact of screening BRCA1/2 mutation carriers by MRI. A health technology assessment
2018 Norwegian Institute of Public Health (NIPH) Bariatric surgery for Type 2 Diabetes and a body mass index below 35